Document is current
Any future updates will be listed below
-
Authors
Qiao, Zhiwei
Uchihara, Yuki
Tsukiyama, Naohiro
Akimoto, Shota
Kaji, Noriko
Fukuda, Koichiro
Mizushima, Tohru
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 1 April 2026
First Online: 22 April 2026
Declarations
:
: All animal experiments were conducted in accordance with the ARRIVE guidelines and in compliance with relevant institutional and national regulations for the care and use of laboratory animals. The experimental protocols in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of the Shonan Health Innovation Park (Shonan iPark).
: Not applicable.
: Tohru Mizushima PhD, president and CEO, Koichiro Fukuda PhD, board director, Zhiwei Qiao PhD, Shota Akimoto, Noriko Kaji PhD, Yuki Uchihara PhD and Naohiro Tsukiyama, employees of LTT Bio-Pharma Co., LTD. LTT Bio-Pharma is the developer of PC-SOD. Tohru Mizushima PhD owns stock in LTT Bio-Pharma Co., LTD.
